Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.


Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Recent publication from @UW researchers shows that combined blockade of #CXCL12, the #NOXA12 target, signaling through CXCR4 and PD-1 can reactivate tumor-specific T cells in the tumor microenvironment of human #pancreascancer:

Happy #birthday, alles Gute, and tanti auguri to our favorite #officedog, Bean!

August’s #BeanoftheMonth is here to remind you that happiness, much like that induced by rolling around in a field of flowers, is key to #business success. This
@StanfordGSB article illustrates 4 principles to creating a #happy #officeenvironment:

Load More...